Literature DB >> 15838070

The ethics of deactivating implanted cardioverter defibrillators.

Jeffrey T Berger1.   

Abstract

Implantable cardioverter defibrillators are life-saving devices for many patients with cardiac disease. Recipients of these devices, nevertheless, often suffer from progressive comorbid and cardiac conditions. Therefore, physicians should anticipate situations in which the defibrillator is no longer desired by the patient or no longer medically appropriate. Near the end of life, many of these patients may decline cardiopulmonary resuscitation. The comanagement of do-not-resuscitate orders and implanted defibrillators can be confusing to patients and physicians alike since the former proscribe the use of electrical cardioversion while the latter provide this precise treatment. Although the use of implanted defibrillators has important ethical implications, few studies have examined these issues, and guidelines have not yet been developed to assist physicians in caring for patients who have received defibrillators. This paper discusses bioethical considerations in disabling implantable cardioverter defibrillators.

Entities:  

Keywords:  Death and Euthanasia

Mesh:

Year:  2005        PMID: 15838070     DOI: 10.7326/0003-4819-142-8-200504190-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

Review 1.  Informed consent in cardiac resynchronization therapy: what should be said?

Authors:  Daniel B Kramer; Dan W Brock; Usha B Tedrow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-09

2.  Patient expectations from implantable defibrillators to prevent death in heart failure.

Authors:  Garrick C Stewart; Joanne R Weintraub; Parakash P Pratibhu; Marc J Semigran; Janice M Camuso; Kimberly Brooks; Sui W Tsang; Mary Susan Anello; Viviane T Nguyen; Eldrin F Lewis; Anju Nohria; Akshay S Desai; Michael M Givertz; Lynne W Stevenson
Journal:  J Card Fail       Date:  2009-11-04       Impact factor: 5.712

3.  [Dying with/despite a pacemaker].

Authors:  S Reith; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-01-04       Impact factor: 0.840

4.  Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Dan W Brock; William H Maisel
Journal:  Heart Rhythm       Date:  2010-07-19       Impact factor: 6.343

5.  Adverse experiences with implantable defibrillators in Oregon hospices.

Authors:  Erik K Fromme; Tanya Lugliani Stewart; Margaret Jeppesen; Susan W Tolle
Journal:  Am J Hosp Palliat Care       Date:  2010-11-25       Impact factor: 2.500

6.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

Review 7.  The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Authors:  Jörg Carlsson; Norbert W Paul; Matthias Dann; Jörg Neuzner; Dietrich Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2012-08-20       Impact factor: 5.594

Review 8.  Within you/without you: biotechnology, ontology, and ethics.

Authors:  Daniel P Sulmasy
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.